BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32483111)

  • 1. PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway.
    Liu D; Lin L; Wang Y; Chen L; He Y; Luo Y; Qi L; Guo Y; Chen L; Han Z; Li G; Li Q; Liu Z; Chen P; Guo H
    Oncogenesis; 2020 Jun; 9(5):58. PubMed ID: 32483111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application.
    Roy SK; Srivastava S; Hancock A; Shrivastava A; Morvant J; Shankar S; Srivastava RK
    J Cell Mol Med; 2023 Feb; 27(3):365-378. PubMed ID: 36625087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p.
    Bai J; Li H; Chen X; Chen L; Hu Y; Liu L; Zhao Y; Zuo W; Zhang B; Yin C
    Front Oncol; 2022; 12():949951. PubMed ID: 36059662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.
    Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C
    J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00942 Promotes Tumor Proliferation and Metastasis in Lung Adenocarcinoma via FZD1 Upregulation.
    Wang R; Wang X; Zhang J; Liu Y
    Technol Cancer Res Treat; 2021; 20():1533033820977526. PubMed ID: 34253104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
    Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
    Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC00968 inhibits proliferation, migration and invasion of lung adenocarcinoma through targeting miR-22-5p/CDC14A axis.
    Wu C; Bian X; Zhang L; Hu Y; Wu Y; Pei T; Han X
    3 Biotech; 2021 Oct; 11(10):433. PubMed ID: 34603911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circle RNA FOXP1 promotes cell proliferation in lung cancer by regulating miR-185-5p/Wnt1 signaling pathway.
    Li O; Kang J; Zhang JJ; Wang J; Hu LW; Li L; Sun YY; Bai Y; Wei QQ; Yan YP; Yi X
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6767-6778. PubMed ID: 32633368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
    Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
    Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma.
    Dong X; Liu Y; Deng X; Shao J; Tian S; Chen S; Huang R; Lin Z; Chen C; Shen L
    Front Cell Dev Biol; 2021; 9():707970. PubMed ID: 34307388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA ST7-AS1, by regulating miR-181b-5p/KPNA4 axis, promotes the malignancy of lung adenocarcinoma.
    Hu RH; Zhang ZT; Wei HX; Ning L; Ai JS; Li WH; Zhang H; Wang SQ
    Cancer Cell Int; 2020 Dec; 20(1):568. PubMed ID: 33327962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways.
    Wang SS; Fang YY; Huang JC; Liang YY; Guo YN; Pan LJ; Chen G
    Oncol Lett; 2019 Sep; 18(3):2939-2954. PubMed ID: 31402959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA ZFPM2-AS1 promotes proliferation via miR-18b-5p/VMA21 axis in lung adenocarcinoma.
    Xue M; Tao W; Yu S; Yan Z; Peng Q; Jiang F; Gao X
    J Cell Biochem; 2020 Jan; 121(1):313-321. PubMed ID: 31297866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21-5p is a Biomarker for Predicting Prognosis of Lung Adenocarcinoma by Regulating PIK3R1 Expression.
    Du J; Qian J; Zheng B; Xu G; Chen H; Chen C
    Int J Gen Med; 2021; 14():8873-8880. PubMed ID: 34858053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.